Insider trades
Mark S. Shearman, Chief Officer of Editas Medicine EDIT, has filed 0 purchases and 1 sale on the open market. The latest trade was on 23/02/13.
Mark S. Shearman
EVP, Chief Scientific Officer
- Company
- Editas Medicine EDIT
- First filing
- 23/02/15
- Trades
- 1 trades
- Buys / sales
- 0 / 1
- 12-month net buying
- No record
- Last trade
- 23/02/13
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Editas MedicineEDIT | Open-market sale | 23/02/13 | 23/02/15 | 2,790 sh | $9.67 | $26,979.3 | −4.1% |